1d
allAfrica.com on MSNUganda conducts first ever Ebola Sudan vaccine trialIt is also the first clinical trial of the vaccine during an outbreak Kampala, Uganda | AGENCIES | In a global first, ...
Most of the world's population is exposed to polluted air and or those living in cities with chronically bad air, the smog ...
1d
Mediaite on MSNAmericans Should Take Trump’s Petty War on the AP PersonallyFervent Trump supporters may cheer, but ordinary Americans should ask themselves: Do they really want a government that ...
TANZANIA’S decision to extend maternity leave for employees who give birth to premature babies marks a significant ...
Mitigating diseases which have significant societal impact starts with an early and accurate diagnosis. Ensuring access to safe, appropriate and ...
The Traffic Enforcement Camera Market is projected to experience significant growth, expanding from USD 2,541.63 million in ...
Elon Musk's Department of Government Efficiency has made swift work of the billionaire's goal to curtail the government. Here ...
1dOpinion
The New Republic on MSNTrump Wants This Amazon Exec to Head a Key Worker Protection GroupTrump wants a former Amazon executive to lead the country’s workplace safety agency. On Wednesday, the president nominated ...
1dOpinion
The New Republic on MSNMexico’s President Threatens to Sue Google for Bowing to TrumpMexican President Claudia Sheinbaum threatened Thursday to sue Google after it changed the name of the Gulf of Mexico in its ...
SANTA ANA, Calif. - NKGen Biotech, Inc. (NASDAQ: NKGN), a clinical-stage biotechnology company with a current market capitalization of $17 million, has received Fast Track designation from the U.S.
Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a device. Personalised ads and content, ad and content measurement, audience ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results